s6y

BIOLIFE SOLUTIONS INC

CIK
834365
Industry
Electromedical & Electrotherapeutic Apparatus
Formerly
CRYOMEDICAL SCIENCES INC

Financials 112

  1. 10-Q Quarterly Report for period ending Jun 30, 2026
  2. 10-Q Quarterly Report for period ending Mar 31, 2026
  3. 10-K/A Annual Report for period ending Dec 31, 2025
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K/A Annual Report for period ending Dec 31, 2024
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 112 financials filings

News 235

  1. 8-K Acquisition or sale completed; Delisting notice; Change to shareholder rights; Change in control; Director or officer change; Charter or bylaw change; Shareholder vote results
  2. 8-K Other events
  3. 8-K Financial results
  4. 8-K Regulation FD disclosure
  5. 8-K Material agreement; Regulation FD disclosure
  6. 8-K Regulation FD disclosure
  7. 8-K Financial results
  8. 8-K Regulation FD disclosure
  9. 8-K Financial results
  10. 8-K Financial results

All 235 news filings

Ownership 1,214

  1. SCHEDULE 13G/A Major shareholder report (passive investor)
  2. SCHEDULE 13G/A Major shareholder report (passive investor)
  3. SCHEDULE 13G/A Major shareholder report (passive investor)
  4. 4 Change in insider ownership
  5. 4 Change in insider ownership
  6. 4 Change in insider ownership
  7. 4 Change in insider ownership
  8. 4 Change in insider ownership
  9. 4 Change in insider ownership
  10. 4 Change in insider ownership

All 1,214 ownership filings

Prospectus 42

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. 425 Merger communication
  5. 425 Merger communication
  6. 425 Merger communication
  7. 425 Merger communication
  8. S-3/A Registration statement for specified transactions by certain issuers
  9. S-3 Registration statement for specified transactions by certain issuers
  10. S-3 Registration statement for specified transactions by certain issuers

All 42 prospectus filings

Proxies 32

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 32 proxies filings

Other 104

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. 25-NSE Removal from exchange listing
  5. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  6. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  7. EFFECT Notice of Effectiveness
  8. EFFECT Notice of Effectiveness
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 104 other filings